Clinical efficacy of Qingpeng ointment in treatment of acute herpes zoster neuralgia
10.3760/cma.j.issn.1671-0290.2021.05.019
- VernacularTitle:青鹏软膏治疗带状疱疹早期神经痛的临床疗效
- Author:
Ziguang ZHOU
1
;
Wenjiao CHEN
;
Aili GOU
;
Li LI
Author Information
1. 郑州市第一人民医院皮肤科，郑州 450000
- Keywords:
Herpes zoster;
Neuralgia;
Early intervention;
Comparative effectiveness research;
Qingpeng ointment
- From:
Chinese Journal of Medical Aesthetics and Cosmetology
2021;27(5):432-435
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the efficacy of Qingpeng ointment in the treatment of early herpes zoster neuralgia.Methods:From January to June 2019, sixty patients with herpes zoster (34 males and 26 females, aged 12 to 48 years, onset time of 1 to 7 days) were randomly divided into experimental group and control group. Both groups were given the same antiviral and neurotrophic therapy after admission. The experimental group was treated with Qingpeng ointment for external use in addition. The numerical rating scale (NRS), sleep score (AIS) and adverse reactions of the two groups were evaluated at pre-treatment, 3, 5, 7, 15 and 30 days after treatment.Results:Compared with pre-treatment, the NRS and AIS scores of the experimental group were significantly reduced at each time from day 3, and the difference was statistically significant. The NRS and AIS scores of the control group were reduced at each time from day 7, and the difference was statistically significant. Compared with control group, the NRS scores of the experimental group on the 3rd, 5th, and 7th days and the AIS scores on the 3rd and 5th days after treatment were lower than those of the control group, and the difference was statistically significant. There were no serious adverse reactions in the two groups.Conclusions:External application of Qingpeng ointment can quickly relieve early neuralgia in patients with herpes zoster, improve the patients＇ sleep, and there is no obvious adverse reaction.
